Skip to content

Search

Showing results for " https://www.galaxus.ch/en/sector/showdiscussion/360hack360-com-visit-kunghaccom-whd8eez7-223334"

Head of Strategy, END RHD (Maternity Leave Cover)

The Kids Research Institute Australia is currently in the process of implementing a new recruitment system. Please click the link below to view and

Triage phone service

Did you know that we now have a 'triage' section on the DiabHQ app with useful documents and a FAQs page.

SNAP-PY

There are an estimated 5000 episodes per year of bloodstream infections due to Staphylococcus aureus (golden staph) in Australia and an associated mortality of 20%. Despite this, there is little clinical trials evidence to guide best management.

Senior Manager, Key Relationships

The Kids Research Institute Australia is currently in the process of implementing a new recruitment system. Please click the link below to view and

Project Manager – Clinical Research

The Kids Research Institute Australia is currently in the process of implementing a new recruitment system. Please click the link below to view and

CliniKids Engagement Coordinator

The Kids Research Institute Australia is currently in the process of implementing a new recruitment system. Please click the link below to view and

Research Assistant, Child Physical Activity, Health and Development Research (PLAYCE)

The Kids Research Institute Australia is currently in the process of implementing a new recruitment system. Please click the link below to view and

T1D Mobile Health App

T1D Mobile Health App It is important for people living with type 1 diabetes (T1D) to engage in a physically active lifestyle, but it can be

MRCF launches Perth-based biotech developing new treatment for Cystic Fibrosis

A The Kids Research Institute Australia spin-off company has received $20 million from the Medical Research Commercialisation Fund to develop a promising new therapy for the treatment of Cystic Fibrosis.

Nasal spray to prevent ear infections closer to fruition thanks to major grant

A nasal spray that could potentially prevent childhood ear infections and reduce antibiotic use is a step closer to clinical trials thanks to a $500,000 CUREator grant.